Acute outbreak of hepatitis C in human immunodeficiency virus-infected patients;Brote epidémico de hepatitis aguda C en pacientes infectados por el virus de la inmunodeficiencia humana

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 33, Issue 1, 2015, Pages 3-8

  Martínez Rebollar, Maria ^a   Mallolas, Josep ^a   Pérez, Iñaki ^a   González Cordón, Ana ^a   Loncà, Montserrat ^a   Torres, Berta ^a   Rojas, Jhon Fredy ^a   Monteiro, Polyana ^a   Blanco, José Luis ^a   Martínez, Esteban ^a   Gatell, José María ^a   Laguno, Montserrat ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Acute hepatitis C; Co infection; Human immunodeficiency virus; Incidence; Sexual transmitted diseases

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN; HEPATITIS C ANTIBODY; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT; MACROGOL; PEGINTERFERON ALPHA2A; RECOMBINANT PROTEIN;

ARTICLE; EPIDEMIC; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 4; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MEN WHO HAVE SEX WITH MEN; NONHUMAN; RETROSPECTIVE STUDY; SEROCONVERSION; SEXUALLY TRANSMITTED DISEASE; ACUTE HEPATITIS C; BODY WEIGHT; DIAGNOSTIC TEST; DRUG RESPONSE; EARLY INTERVENTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; RNA ANALYSIS; SYMPTOM; UNPROTECTED SEX; ACUTE DISEASE; ADULT; COMBINATION DRUG THERAPY; COMORBIDITY; IMMUNOCOMPROMISED PATIENT; MALE; SPAIN;

ACUTE DISEASE; ADULT; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; COMORBIDITY; DRUG THERAPY, COMBINATION; HEPATITIS C; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INTERFERON-ALPHA; MALE; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; RIBAVIRIN; SEXUALLY TRANSMITTED DISEASES; SPAIN;

EID: 84921323599     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2014.05.013     Document Type: Article

References (46)

1. Van de Laar TJ, van der Bij AK, Prins M, Bruisten SM, Brinkman K, Ruys TA, et al. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis. 2007;196:230-8.
2. Gotz HM, van Doornum G, Niesters HG, den Hollander JG, Thio HB, de Zwart O. A cluster of acute hepatitis C virus infection among men who have sex with men - results from contact tracing and public health implications. AIDS. 2005;19:969-74.
3. Danta M, Dusheiko GM. Acute HCV in HIV-positive individuals - a review. Curr Pharm Des. 2008;14:1690-7.
4. Serpaggi J, Chaix ML, Batisse D, Dupont C, Vallet-Pichard A, Fontaine H, et al. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy. AIDS. 2006;20:233-40.
5. Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, et al. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr. 2006;41:31-6.
6. Bateman K. Factor S, Gutierrez J. Evidence for sexual transmission of hepatitis C virus infection in men who have sex with men (MSM) in New York City. 14th International Symposium on Hepatitis C Virus and Related Viruses, 9-13th September, Glasgow, 2007. Abstract P48.
7. Fierer D, Fishman S, Uriel A, Carriero D, Factor S, Mullen M, et al. Characterization of an Outbreak of Acute HCV Infection in HIV-infected Men in New York City. 16th conference on retroviruses and opportunistic infections. Montreal. February 2009. Poster 802.
8. Matthews GV, Hellard M, Haber P, Yeung B, Marks P, Baker D, et al. Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clin Infect Dis. 2009;48:650-8.
9. Giraudon I, Ruf M, Maguire H, Charlett A, Ncube F, Turner J, et al. Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: Is this an outbreak? Sex Transm Infect. 2008;84:111-5.
10. Van de Laar T, Pybus O, Bruisten S, Brown D, Nelson M, Bhagani S, et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology. 2009;136:1609-17.
11. Hisada M, O'Brien TR, Rosenberg PS, Goedert JJ. Virus load and risk of heterosexual transmission of human immunodeficiency virus and hepatitis C virus by men with haemophilia. The Multicenter Hemophilia Cohort Study. J Infect Dis. 2000;181:1475-8.
12. Leruez-Ville M, Kunstmann JM, de Almeida M, Rouzioux C, Chaix ML. Detection of hepatitis C virus in the semen of infected men. Lancet. 2000;356:42-3.
13. Pasquier C, Bujan L, Daudin M, Righi L, Berges L, Thauvin L, et al. Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV. J Med Virol. 2003;69:344-9.
14. Ghosn J, Pierre-Francois S, Thibault V, Duvivier C, Tubiana R, Simon A, et al. Acute hepatitis C in HIV-infected men who have sex with men. HIV Med. 2004;5:303-6.
15. Desquilbet L, Deveau C, Goujard C, Hubert JB, Derouineau J, Meyer L, et al. Increase in at-risk sexual behaviour among HIV-1-infected patients followed in the French PRIMO cohort. AIDS. 2002;16:2329-33.
16. Urbanus AT, van de Laar TJ, Stolte IG, Schinkel J, Heijman T, Coutinho RA, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: An expanding epidemic. AIDS. 2009;23:F1-7.
17. Thiers V, Jaffredo F, Tuveri R, Chodan N, Brechot C. Development of a simple restriction fragment length polymorphism (RFLP) based assay for HCV genotyping and comparative analysis with genotyping and serotyping tests. J Virol Methods. 1997;65:9-17.
18. Orsetti E, Staffolani S, Gesuita R, de Iaco G, Marchionni E, Brescini L, et al. Changing characteristics and risk factors of patients with and without incident HCV infection among HIV-infected individuals. Infection. 2013;41:987-90.
19. Laguno M, Martinez-Rebollar M, Perez I, Costa J, Larrousse M, Calvo M, et al. Low rate of sustained virological response in an outbreak of acute hepatitis C in HIV-infected patients. AIDS Res Hum Retroviruses. 2012;28:1294-300.
20. Montoya-Ferrer A, Fierer DS, Alvarez-Alvarez B, de Gorgolas M, Fernandez-Guerrero ML. Acute hepatitis C outbreak among HIV-infected men, Madrid, Spain. Emerg Infect Dis. 2011;17:1560-2.
21. Sanchez C, Plaza Z, Vispo E, de Mendoza C, Barreiro P, Fernandez-Montero JV, et al. Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain. Liver Int. 2013;33:1357-62.
22. Van de Laar TJ, Matthews GV, Prins M, Danta M. Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. AIDS. 2010;24:1799-812.
23. Morin T, Pariente A, Lahmek P, Rabaud C, Silvain C, Cadranel JF, et al. Acute hepatitis C: Analysis of a 126-case prospective, multicenter cohort. Eur J Gastroenterol Hepatol. 2010;22:157-66.
24. Stellbrink H-J, Schewe CK, Vogel M, et al. Incidence, Genotype Distribution, and Prognosis of Sexually Transmitted Acute Hepatitis C in a Cohort of HIV-infected Patients. 17th Conference on Retroviruses and Opportunistic Infections (CROI 2010). San Francisco, USA. February 16-19, 2010. Abstract 639.
25. Matthews GV, Dore GJ. Optimal duration of treatment for acute hepatitis C in human immunodeficiency virus-positive individuals? Hepatology. 2011;53:1055-6.
26. Van de Laar TJ, Paxton WA, Zorgdrager F, Cornelissen M, de Vries HJ. Sexual transmission of hepatitis C virus in human immunodeficiency virus-negative men who have sex with men: A series of case reports. Sex Transm Dis. 2011;38:102-4.
27. Alary M, Joly JR, Vincelette J, Lavoie R, Turmel B, Remis RS. Lack of evidence of sexual transmission of hepatitis C virus in a prospective cohort study of men who have sex with men. Am J Public Health. 2005;95:502-5.
28. Dominguez S, Ghosn J, Valantin MA, Schruniger A, Simon A, Bonnard P, et al. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients. AIDS. 2006;20:1157-61.
29. Gilleece YC, Browne RE, Asboe D, Atkins M, Mandalia S, Bower M, et al. Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin. J Acquir Immune Defic Syndr. 2005;40:41-6.
30. Hare B, Marks K, Luetkemeyer A, Charlebois E, Cloherty G, Glesby M, et al. Kinetically Guided pegIFN and RBV Therapy for HIV+ Adults Co-infected with Acute HCV. Paper # 959. 18th Conference on Retroviruses and opportunist infections. February 2011, Boston. 2011.
31. Vogel M, Nattermann J, Baumgarten A, Klausen G, Bieniek B, Schewe K, et al. Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals. Antivir Ther. 2006;11:1097-101.
32. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies. J Viral Hepat. 2006;13:34-41.
33. Gerlach T, Zachoval R, Gruener N, Jung M, Ulsenheimer A, Schraut W, et al. Acute hepatitis C: Natural course and response to antiviral treatment. Hepatology. 2001;34:341A.
34. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461:399-401.
35. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009;461:798-801.
36. Interleukin 28 B genotype is a potent predictor of response to therapy with pegylated interferon plus ribavirin in HIV/HCV coinfected patients; 2010.
37. Nattermann J, Vogel M, Nischalke HD, Danta M, Mauss S, Stellbrink HJ, et al. Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C. J Infect Dis. 2011;203:595-601.
38. Boesecke C, Rockstroh JK. Acute hepatitis C in patients with HIV. Semin Liver Dis. 2012;32:130-7.
39. Boesecke C, Wedemeyer H, Rockstroh JK. Diagnosis and treatment of acute hepatitis C virus infection. Infect Dis Clin North Am. 2012;26:995-1010.
40. Vogel M, Nattermann J, Baumgarten A, Klausen G, Bieniek B, Schewe K, et al. Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals. Antivir Ther. 2006;11:1097-101.
41. Piroth L, Larsen C, Binquet C, Alric L, Auperin I, Chaix ML, et al. Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study. Hepatology. 2010;52:1915-21.
42. European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel. Acute hepatitis C in HIV-infected individuals: Recommendations from the European AIDS Treatment Network (NEAT) consensus conference. AIDS. 2011;25:399-409.
43. Fierer D. Treatment of acute hepatitis C in HIV-infected MSM incorporating telaprevir. Abstract 156LB. 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, USA, 3-6 Mar, 2013.
44. Vogel M, Bieniek B, Jessen H, Schewe CK, Hoffmann C, Baumgarten A, et al. Treatment of acute hepatitis C infection in HIV-infected patients: A retrospective analysis of eleven cases. J Viral Hepat. 2005;12:207-11.
45. Dominguez S, Ghosn J, Valantin MA, Schruniger A, Simon A, Bonnard P, et al. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients. AIDS. 2006;20:1157-61.
46. Vogel M, Dominguez S, Bhagani S, Azwa A, Page E, Guiguet M, et al. Treatment of acute HCV infection in HIV-positive patients: Experience from a multicentre European cohort. Antivir Ther. 2010;15:267-79.